S. Jide-Banwo

Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial

S. Grace, J. North, M. Lowdell, 2015, PloS one.

Tumor‐primed natural killer cells from patients with multiple myeloma lyse autologous, NK‐resistant, bone marrow‐derived malignant plasma cells

J. North, E. Katodritou, E. Terpos, 2011, American journal of hematology.